175 related articles for article (PubMed ID: 24185122)
1. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
[TBL] [Abstract][Full Text] [Related]
5. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
[TBL] [Abstract][Full Text] [Related]
6. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.
Quan ZW; Wu K; Wang J; Shi W; Zhang Z; Merrell RC
J Am Coll Surg; 2001 Oct; 193(4):380-3. PubMed ID: 11584965
[TBL] [Abstract][Full Text] [Related]
7. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
8. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma.
Sun XN; Cao WG; Wang X; Wang Q; Gu BX; Yang QC; Hu JB; Liu H; Zheng S
Tumour Biol; 2011 Dec; 32(6):1183-90. PubMed ID: 21853312
[TBL] [Abstract][Full Text] [Related]
10. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
[TBL] [Abstract][Full Text] [Related]
11. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
13. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
14. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
[TBL] [Abstract][Full Text] [Related]
17. Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma.
Hou X; Wei JC; Fu JH; Wang X; Luo RZ; He JH; Zhang LJ; Lin P; Yang HX
Ann Surg Oncol; 2015 Oct; 22(11):3666-73. PubMed ID: 25652047
[TBL] [Abstract][Full Text] [Related]
18. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma.
Zhi YH; Liu RS; Song MM; Tian Y; Long J; Tu W; Guo RX
World J Gastroenterol; 2005 Jun; 11(24):3724-8. PubMed ID: 15968728
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
